Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Marimed (MRMD) Other Non Operating Income (2017 - 2025)

Historic Other Non Operating Income for Marimed (MRMD) over the last 10 years, with Q3 2025 value amounting to $19000.0.

  • Marimed's Other Non Operating Income changed N/A to $19000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $36000.0, marking a year-over-year increase of 10040.34%. This contributed to the annual value of -$50000.0 for FY2024, which is 9952.07% up from last year.
  • Latest data reveals that Marimed reported Other Non Operating Income of $19000.0 as of Q3 2025.
  • Over the past 5 years, Marimed's Other Non Operating Income peaked at $1.0 million during Q1 2022, and registered a low of -$8.9 million during Q4 2023.
  • Moreover, its 5-year median value for Other Non Operating Income was -$90500.0 (2022), whereas its average is -$675250.0.
  • As far as peak fluctuations go, Marimed's Other Non Operating Income skyrocketed by 10030000.0% in 2022, and later tumbled by 577748.34% in 2023.
  • Quarter analysis of 5 years shows Marimed's Other Non Operating Income stood at -$169000.0 in 2021, then rose by 10.65% to -$151000.0 in 2022, then plummeted by 5777.48% to -$8.9 million in 2023, then skyrocketed by 99.66% to -$30000.0 in 2024, then skyrocketed by 163.33% to $19000.0 in 2025.
  • Its Other Non Operating Income stands at $19000.0 for Q3 2025, versus $17000.0 for Q2 2025 and -$30000.0 for Q2 2024.